Merson James
SEC insider (Form 3/4/5 filer). CIK 0002020898. Director at Cidara Therapeutics, Inc. (CDTX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SAN DIEGO, CA.
Companies Merson James has filed insider reports for
- Cidara Therapeutics, Inc. (CDTX): Director
Merson James
CIK: 0002020898
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cidara Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
4.3K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
2.1K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
11.1K shares- - Jun 18, 2025CDTX
Cidara Therapeutics, Inc.
AwardDirectStock Option (right to buy)
11.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 4,250 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 2,125 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 11,100 | - | - | Direct |
| Jun 18, 2025 | CDTX Cidara Therapeutics, Inc. | Award Stock Option (right to buy) | 11,100 | - | - | Direct |
1-4 of 4 transactions